Novocure

Forecast & Rating7 analysts currently cover Novocure, with about 57.1% giving a positive rating — meaning they expect the stock to rise. The average price target is $27.14, about 52.7% upside from the current price of $17.77. Price targets range from $17.00 to $52.00 — a wide spread, showing clear disagreement over just how much Novocure can rise. Historically, about 71.2% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Novocure are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 30, 2026; for reference only and not investment advice.